IP Library Granted Patent US 6,939,486
Granted Patent B2
US 6,939,486 · App. 10/180,797 · Granted Sep 6, 2005

Apparatus and method for making intraocular lenses

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,939,486
App. No.
10/180,797
Granted
Sep 6, 2005
Kind
B2
Abstract

Method and apparatus for molding an IOL comprising first and second mold halves each having an optic forming surface and haptic forming surfaces which together define a mold cavity in the shape of the IOL to be molded therein when the mold halves are assembled together. An injection port is formed and connects to one of said haptic forming surfaces or the optic forming surface wherethrough a polymerizable material is injected into the mold cavity. A venting port is formed and connects to another haptic wherethrough air escapes from the mold cavity as the polymerizable material is injected through the injection port.

Claims (61)

1. A method for molding a single-piece IOL having an optic and first and second haptics connected to said optic, said method comprising the steps of:

providing a mold having first and second mold halves, each of said mold halves having an optic forming surface and first and second haptic forming surfaces, the optic forming surfaces and the first and second haptic forming surfaces together forming a mold cavity in a shape of said IOL when said mold halves are assembled together, said first and second haptic forming surfaces each connected to said optic forming surface, said haptic forming surfaces of the mold halves further defining looped haptics when the mold halves are assembled together;

providing an injection port connected to said first haptic forming surfaces when said mold halves are assembled together;

providing a venting port connected to said second haptic forming surfaces when said mold halves are assembled together;

assembling said first and second mold halves together while aligning said optic forming surfaces and said first and second haptic forming surfaces on each of said first and second mold halves, respectively, and thereby forming said mold cavity;

injecting a quantity of polymerizable material through said injection port into said mold cavity with air simultaneously escaping from said mold cavity through said venting port;

curing said polymerizable material to form said IOL; and

separating said mold halves and releasing said IOL therefrom.

2. The method of claim 1 , further comprising the step of providing an alternate injection port connected to said optic forming surface when said mold halves are assembled together.

3. The method of claim 1 wherein said mold halves are substantially cylindrically shaped.

4. The method of claim 1 wherein said mold halves are substantially rectangularly shaped.

5. The method of claim 1 wherein said mold halves include means for aligning said optic forming surfaces and said haptic forming surfaces on said first and second mold halves, respectively, as said mold halves are being assembled together.

6. The method of claim 1 wherein said IOL is an open-looped IOL having first and second haptics each having an end attached to said optic and an opposite, free end, and wherein said first and second mold halves have first and second haptic forming surfaces each having an attached end and an opposite free end, and wherein said injection port is connected to said free end of said first haptic forming surface and said venting port is connected to said free end of said second haptic forming surface when said mold halves are assembled together.

7. The method claim 1 wherein said IOL is a dosed-looped IOL having first and second haptics each having first and second ends attached to said optic, and wherein said first and second mold halves each have first and second haptic forming surfaces, and wherein said injection port is connected to said first haptic forming surface and said venting port is connected to said second haptic forming surface when said mold halves are assembled together.

8. A method for molding an IOL having an optic and first and second open-looped haptics, said haptics each having an end connected to said optic and an opposite free end, said method comprising the steps of:

providing a mold having first and second mold halves, each of said mold halves having an optic forming surface and first and second haptic forming surfaces, the optic forming surfaces and the haptic forming surfaces together forming a mold cavity in a shape of said IOL when said mold halves are assembled together, said first and second haptic forming surfaces each having an end connected to said optic and an opposite, free end, and said first and second haptic forming surfaces defining said open-looped haptics;

providing an injection port connected to said free ends of said first haptic forming surfaces when said mold halves are assembled together;

providing a venting port connected to said free ends of said second haptic forming surfaces when said mold halves are assembled together;

assembling said first and second mold halves together while aligning said optic forming surfaces and said first and second haptic forming surfaces on each of said first and second mold halves, respectively, and thereby forming said mold cavity;

injecting a quantity of polymerizable material through said injection port into said mold cavity with air simultaneously escaping from said mold cavity through said venting port;

curing said polymerizable material to form said IOL; and

separating said mold halves and releasing said IOL therefrom.

9. A method for molding a single-piece IOL having an optic and first and second closed-looped haptics, said haptics each having first and second ends and a loop portion extending therebetween, said method comprising the steps of:

providing a mold having first and second mold halves, each of said mold halves having an optic forming surface and first and second haptic forming surfaces, all of which surfaces form a mold cavity in a shape of said IOL when said mold halves are assembled together, said first end second ends of said haptic forming surfaces connected to said optic forming surface, and said first and second haptic forming surfaces defining said closed-looped haptics;

providing an injection part connected to said first haptic forming surfaces when said mold halves are assembled together;

providing a venting port extending from said second haptic forming surfaces when said mold halves are assembled together;

assembling said first and second mold halves together while aligning said optic forming surfaces and haptic forming surfaces on each of said first and second mold halves and thereby forming said mold cavity;

injecting a quantity of polymerizable material through said injection port into said mold cavity with air simultaneously escaping through said venting port;

curing said polymerizable material to form said IOL; and

separating said mold halves and releasing said IOL therefrom.

10. A method for molding a single-piece IOL having an optic and first and second haptics connected to said optic, said method comprising the steps of:

providing a mold having first and second mold halves, each of said mold halves having an optic forming surface and first and second haptic forming surfaces, the optic forming surfaces and the first and second haptic forming surfaces together forming a mold cavity in a shape of said IOL when said mold halves are assembled together, said first and second haptic forming surfaces each connected to said optic forming surface, said haptic forming surfaces of the mold halves further defining looped haptics when the mold halves are assembled together;

providing an injection port connected to said optic forming surfaces when said mold halves are assembled together;

providing a venting port connected to at least one of said first and second haptic forming surfaces when said mold halves are assembled together;

assembling said first and second mold halves together while aligning said optic forming surfaces and said first and second haptic forming surfaces on each of said first and second mold halves, respectively, and thereby forming said mold cavity;

injecting a quantity of polymerizable material through said injection port into said mold cavity with air simultaneously escaping from said mold cavity through said venting port;

curing said polymerizable material to form said IOL; and

separating said mold halves and releasing said IOL therefrom.

11. A method for molding a single-piece IOL having an optic and at least one haptic connected to said optic, said method comprising the steps of:

providing a mold having first and second mold halves, each of said mold halves having an optic farming surface and at least one haptic forming surface, the optic forming surfaces and the haptic forming surface together forming a mold cavity in a shape of said IOL when said mold halves are assembled together, said first and second haptic forming surfaces each connected to said optic forming surface, said haptic forming surfaces of the mold halves further defining a looped haptic when the mold halves are assembled together which form a mold cavity in the shape of said IOL when said mold halves are assembled together, said at least one haptic forming surface connected to said optic forming surface;

providing an injection port connected to said optic forming surfaces when said mold halves are assembled together;

providing a venting port connected to said at least one haptic forming surfaces when said mold halves are assembled together;

assembling said first and second mold halves together while aligning said optic forming surfaces and said at least one haptic forming surface on each of said first and second mold halves, respectively, and thereby forming said mold cavity;

injecting a quantity of polymerizable material through said injection port into said mold cavity with air simultaneously escaping from said mold cavity through said venting port;

curing said polymerizable material to form said IOL; and

separating said mold halves and releasing said IOL therefrom.

12. The method of claim 1 , and further comprising the step of providing a damping tool for assembling said mold halves together.

13. The method of claim 12 wherein said mold halves each include means for aligning said optic forming surfaces and said haptic forming surfaces on said first and second mold halves as said mold halves are being assembled.

14. The method of claim 13 wherein said alignment means are operable to clamp said mold halves together.

15. The method of claim 14 wherein said clamping tool includes means for releasing the clamped mold halves such that said first and second mold halves may be separated from each other.

16. The method of claim 15 wherein said alignment means comprise a boss and recess fitting on said first and second mold halves, respectively.

17. The method of claim 16 wherein said damp releasing means on said damping tool comprises a shearing pin.

18. The method of claim 1 , and further comprising the step of providing at least two different polymerizable materials for sequential injection through said injection port whereby said IOL is comprised of said at least two different polymerizable materials.

19. The method of claim 18 , whereby said at leant two polymerizable materials comprise a hydrogel and PMMA.

20. An apparatus for molding a single-piece IOL having an optic and first and second haptics connected to said optic, said apparatus comprising:

a mold having first and second mold halves, each of said mold halves having an optic forming surface and first and second haptic forming surfaces, the optic forming surfaces and the first and second haptic forming surfaces together forming a mold cavity in a shape of said IOL when said mold halves are assembled together, said first and second haptic forming surfaces each connected to said optic forming surface, said haptic forming surfaces of the mold halves further defining looped haptics when the mold halves are assembled together;

an injection port connected to said first haptic forming surfaces when said mold halves are assembled together;

a venting port connected to said second haptic forming surfaces when said mold halves are assembled together;

said first and second mold halves adapted to be assembled together with said optic forming surfaces and said first and second haptic forming surfaces on each of said first and second mold halves in alignment, respectively, and thereby forming said mold cavity;

said injection port adapted to receive a quantity of polymerizable material therethrough and into said mold cavity with air being allowed to escape from said mold cavity through said venting port;

said polymerizable material being cured to form said IOL whereupon said mold halves are separated to retrieve said IOL therefrom.

Assignments (27)
RELEASE OF SECURITY INTEREST Recorded Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC; DOW PHARMACEUTICAL SCIENCES, INC.; ECR PHARMACEUTICALS CO., INC.; LABORATOIRE CHAUVIN S.A.S.; MEDICIS PHARMACEUTICAL CORPORATION; ONPHARMA INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, LTD.; SALIX PHARMACEUTICALS, INC.; SANTARUS, INC.; SOLTA MEDICAL, INC.; SYNERGETICS USA, INC.; TECHNOLAS PERFECT VISION GMBH; VALEANT CANADA LP; VALEANT PHARMACEUTICALS INTERNATIONAL; VALEANT PHARMACEUTICALS INTERNATIONAL, INC.; VALEANT PHARMACEUTICALS NORTH AMERICA LLC; WIRRA IP PTY LIMITED; VALEANT PHARMA POLAND SP. Z O.O.; VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.; VALEANT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 073637/0001 →
RELEASE OF SECURITY INTEREST Recorded Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.
Reel/Frame 073637/0126 →
RELEASE OF SECURITY INTEREST Recorded Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH AMERICAS, INC.
Reel/Frame 073654/0242 →
ASSIGNMENT OF SECURITY INTEREST IN PATENTS PREVIOUSLY RECORDED AT REEL/FRAME (059913/0548) Recorded Aug 14, 2025
From: CITIBANK, N.A., AS RESIGNING AGENT
To: JPMORGAN CHASE BANK, N.A., AS SUCCESSOR AGENT
Reel/Frame 072469/0091 →
RELEASE OF SECURITY INTEREST Recorded Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD; SANTARUS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; HUMAX PHARMACEUTICAL S.A.; SOLTA MEDICAL IRELAND LIMITED; BAUSCH & LOMB MEXICO, S.A. DE C.V.; BAUSCH+LOMB OPS B.V.; BAUSCH HEALTH AMERICAS, INC.; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH HOLDCO LIMITED; BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC); BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA); BAUSCH HEALTH US, LLC; BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.; ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.); ORAPHARMA, INC.; PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.); SOLTA MEDICAL DUTCH HOLDINGS B.V.; V-BAC HOLDING CORP.; VRX HOLDCO LLC; 1261229 B.C. LTD.; 1530065 B.C. LTD.
Reel/Frame 070778/0199 →
OMNIBUS PATENT SECURITY RELEASE AGREEMENT (REEL/FRAME 045444/0634) Recorded Nov 2, 2022
From: THE BANK OF NEW YORK MELLON
To: BAUSCH & LOMB INCORPORATED; LABORATOIRE CHAUVIN S.A.S.; TECHNOLAS PERFECT VISION GMBH; THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 061872/0295 →
OMNIBUS PATENT SECURITY RELEASE AGREEMENT (REEL/FRAME 056811/0814) Recorded Nov 2, 2022
From: THE BANK OF NEW YORK MELLON
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 061872/0669 →
OMNIBUS PATENT SECURITY RELEASE AGREEMENT (REEL/FRAME 059121/0001) Recorded Nov 2, 2022
From: THE BANK OF NEW YORK MELLON
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 061873/0001 →
OMNIBUS PATENT SECURITY RELEASE AGREEMENT (REEL/FRAME 043251/0932) Recorded Nov 2, 2022
From: THE BANK OF NEW YORK MELLON
To: BAUSCH & LOMB INCORPORATED; TECHNOLAS PERFECT VISION GMBH
Reel/Frame 061872/0099 →
OMNIBUS PATENT SECURITY RELEASE AGREEMENT (REEL/FRAME 048556/0758) Recorded Nov 2, 2022
From: THE BANK OF NEW YORK MELLON
To: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH COMPANIES INC.; TECHNOLAS PERFECT VISION GMBH; THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 061872/0484 →
RELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS (REEL/FRAME 045444/0299) Recorded Oct 26, 2022
From: BARCLAYS BANK PLC
To: BAUSCH & LOMB INCORPORATED; TECHNOLAS PERFECT VISION GMBH; THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES; PF CONSUMER HEALTHCARE 1 LLC; LABORATOIRE CHAUVIN S.A.S.
Reel/Frame 061779/0001 →
RELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS (REEL/FRAME 034749/0689) Recorded Oct 26, 2022
From: BARCLAYS BANK PLC
To: BAUSCH & LOMB INCORPORATED; UNIVERSITY OF ROCHESTER
Reel/Frame 061778/0146 →
RELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS (REEL/FRAME 031156/0508) Recorded Oct 26, 2022
From: BARCLAYS BANK PLC
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 061778/0446 →
PATENT SECURITY AGREEMENT Recorded May 10, 2022
From: BAUSCH & LOMB INCORPORATED
To: CITIBANK, N.A. AS COLLATERAL AGENT
Reel/Frame 059913/0548 →
SECURITY AGREEMENT Recorded Feb 10, 2022
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH AMERICAS, INC.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 059121/0001 →
SECURITY INTEREST Recorded Jun 8, 2021
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH AMERICAS, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 056811/0814 →
SECURITY INTEREST Recorded Mar 11, 2019
From: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 048556/0758 →
SECURITY INTEREST Recorded Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC; DOW PHARMACEUTICAL SCIENCES, INC.; ECR PHARMACEUTICALS CO., INC.; LABORATOIRE CHAUVIN S.A.S.; MEDICIS PHARMACEUTICAL CORPORATION; ONPHARMA INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, LTD.; SALIX PHARMACEUTICALS, INC.; SANTARUS, INC.; SOLTA MEDICAL, INC.; SYNERGETICS USA, INC.; TECHNOLAS PERFECT VISION GMBH; VALEANT CANADA LP; VALEANT PHARMACEUTICALS INTERNATIONAL; VALEANT PHARMACEUTICALS INTERNATIONAL, INC.; VALEANT PHARMACEUTICALS NORTH AMERICA LLC; WIRRA IP PTY LIMITED; VALEANT PHARMA POLAND SP. Z O.O.; VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.; VALEANT PHARMACEUTICALS IRELAND LIMITED
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 045444/0299 →
SECURITY INTEREST Recorded Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC; DOW PHARMACEUTICAL SCIENCES, INC.; ECR PHARMACEUTICALS CO., INC.; LABORATOIRE CHAUVIN S.A.S.; MEDICIS PHARMACEUTICAL CORPORATION; ONPHARMA INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, LTD.; SALIX PHARMACEUTICALS, INC.; SANTARUS, INC.; SOLTA MEDICAL, INC.; SYNERGETICS USA, INC.; TECHNOLAS PERFECT VISION GMBH; VALEANT CANADA LP; VALEANT PHARMACEUTICALS INTERNATIONAL; VALEANT PHARMACEUTICALS INTERNATIONAL, INC.; VALEANT PHARMACEUTICALS NORTH AMERICA LLC; WIRRA IP PTY LIMITED; VALEANT PHARMA POLAND SP. Z O.O.; VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.; VALEANT PHARMACEUTICALS IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 045444/0634 →
SECURITY INTEREST Recorded Jul 19, 2017
From: BAUSCH & LOMB INCORPORATED
To: THE BANK OF NEW YORK MELLON
Reel/Frame 043251/0932 →
NOTICE OF SUCCESSION OF AGENCY Recorded Jan 9, 2015
From: GOLDMAN SACHS LENDING PARTNERS, LLC
To: BARCLAYS BANK PLC, AS SUCCESSOR AGENT
Reel/Frame 034749/0689 →
SECURITY AGREEMENT Recorded Sep 4, 2013
From: BAUSCH & LOMB INCORPORATED
To: GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
Reel/Frame 031156/0508 →
RELEASE OF SECURITY INTEREST Recorded Aug 13, 2013
From: CITIBANK N.A., AS ADMINISTRATIVE AGENT
To: WP PRISM INC. (N/K/A BAUSCH & LOMB HOLDINGS INC.); BAUSCH & LOMB INCORPORATED; ISTA PHARMACEUTICALS
Reel/Frame 030995/0444 →
SECURITY AGREEMENT Recorded Aug 6, 2012
From: BAUSCH & LOMB INCORPORATED; EYEONICS, INC.
To: CITIBANK N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 028728/0645 →
RELEASE OF SECURITY INTEREST Recorded Aug 5, 2012
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 028726/0142 →
SECURITY AGREEMENT Recorded Mar 26, 2008
From: BAUSCH & LOMB INCORPORATED; WP PRISM INC.; B&L CRL INC.; B&L CRL PARTNERS L.P.; B & L DOMESTIC HOLDINGS CORP.; B&L FINANCIAL HOLDINGS CORP.; B&L SPAF INC.; B&L VPLEX HOLDINGS, INC.; BAUSCH & LOMB CHINA, INC.; BAUSCH & LOMB INTERNATIONAL INC.; BAUSCH & LOMB REALTY CORPORATION; BAUSCH & LOMB SOUTH ASIA, INC.; BAUSCH & LOMB TECHNOLOGY CORPORATION; IOLAB CORPORATION; RHC HOLDINGS, INC.; SIGHT SAVERS, INC.; WILMINGTON MANAGEMENT CORP.; WILMINGTON PARTNERS L.P.; B&L MINORITY DUTCH HOLDINGS LLC
To: CREDIT SUISSE
Reel/Frame 020733/0765 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 25, 2002
From: DERYKE, KEVIN J.; DOBNER, MICHAEL H.; HOVEY, LARRY C.; MOOREHEAD, MICHAEL L.
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 013071/0382 →